Evaluation of cytokines in nasal secretions in children with bronchial asthma and concomitant upper respiratory tract pathology

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Background. In children with bronchial asthma (BA), the upper respiratory tract pathology (URT; allergic rhinitis, adenoid hypertrophy) is often observed, which contributes to the uncontrolled BA course. Inflammation in both the upper and lower airways can be uniform, which may aggravate the BA course. However, it is necessary to differentiate the type of inflammation, which can be caused by a Th-2 or Th-1 immune response. Depending on the type of inflammation, further treatment tactics will depend. Therefore, it is important to study the local immunological status in patients with BA and URT pathology.

Objective. Evaluation of the interleukin-4 (IL-4), IL-5, IL-10, IL-8, IL-18, tumor necrosis factor-α (TNF-α) levels in nasal secretions in children with adenoid hypertrophy (AH), allergic rhinitis (AR) and their combination with BA.

Methods. The study involved 107 children aged 4 to 10 years. Group 1 consisted of children diagnosed with BA in combination with AR and AH (n=38); Group 2 (comparison) – children diagnosed with AR (n=32); Group 3 – children with AH (n=25); control group – 12 healthy children. The IL-4, IL-8, IL-18, IL-10, TNF-α levels were determined in nasal secretions using enzyme-linked immunosorbent assay (ELISA) kits from Vector-Best JSC (Russia, Novosibirsk). The IL-5 concentration was determined in nasal secretions by solid-phase ELISA using the IL-5 Human ELISA Kit from Invitrogen Thermo Fisher Scientific (USA). Cytokine concentrations were measured using a Multiscan Fc immunoassay analyzer (Thermo Scientific) and expressed in pg/ml.

Results. In children with BA in combination with AR and AH, a significant increase in the IL-4, IL-5, IL-10 and TNF-α levels was obtained, in children with AR – only IL-4 and IL-5 (p<0.05) .

Conclusion. The allergic process implies the same tendency for the production of cytokines, regardless of the nosological form, and the combination of nosologies leads to more pronounced inflammation. AH does not affect the local cytokine status, however, it contributes to the severity of clinical manifestations.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Alina Turovskaya

Penza Institute for Advanced Medical Education – Branch Campus of RMACPE; Medguard-Penza LLC

Email: trushina.lena@mail.ru
ORCID iD: 0000-0002-5138-808X
Ресей, Penza; Penza

Elena Kostina

Penza Institute for Advanced Medical Education – Branch Campus of RMACPE

Email: trushina.lena@mail.ru
ORCID iD: 0000-0003-1797-8040
Ресей, Penza

Nadezhda Baranova

Penza Institute for Advanced Medical Education – Branch Campus of RMACPE

Email: trushina.lena@mail.ru
ORCID iD: 0000-0002-2991-0898
Ресей, Penza

Andrey Popov

Penza Institute for Advanced Medical Education – Branch Campus of RMACPE; Penza Regional Children’s Clinical Hospital n.a. N.F. Filatov

Email: trushina.lena@mail.ru
ORCID iD: 0000-0002-3549-5774
Ресей, Penza; Penza

Ekaterina Orlova

Penza Institute for Advanced Medical Education – Branch Campus of RMACPE

Email: trushina.lena@mail.ru
ORCID iD: 0000-0003-1402-2940
Ресей, Penza

Elena Trushina

Penza Institute for Advanced Medical Education – Branch Campus of RMACPE

Хат алмасуға жауапты Автор.
Email: trushina.lena@mail.ru
ORCID iD: 0000-0001-5673-9195
SPIN-код: 2164-6580

Cand. Sci. (Med.), Associate Professor at the Department of Pulmonology and Phthisiology

Ресей, Penza

Әдебиет тізімі

  1. Клинические рекомендации – Бронхиальная астма. Утверждены Минздравом РФ, 2021. [Электронный ресурс]. [Clinical guidelines – Bronchial asthma. Approved by the Ministry of Health of the Russian Federation, 2021. [Electronic resource]. (In Russ.)]. URL: https://cr.minzdrav.gov.ru/schema/359_2
  2. Ненашева Н.М. Бронхиальная астма и сопутствующие заболевания: в фокусе аллергический ринит. Лечебное дело. 2014;1:18–26. [Nenasheva N.M. Bronchial Asthma and Related Diseases: the Focus of Allergic Rhinitis. Lechebnoe delo. 2014;1:18–26. (In Russ.)].
  3. Белан Э.Б., Садчикова Т.Л., Панина А.А. и др. Влияние поливалентной аллергенспецифической иммунотерапии на развитие бронхиальной астмы у детей с аллергическим ринитом. Вестник Волгоградского государственного медицинского университета. 2014;3(51):83–4. [Belan E.B., Sadchikova T.L., Panina A.A., et al. The effect of polyvalent allergen-specific immunotherapy on the development of bronchial asthma in children with allergic rhinitis. Vestnik Volgogradskogo gosudarstvennogo medicinskogo universiteta. 2014;3(51):83–84. (In Russ.)].
  4. Пухлик С.М., Неверт Э.Г., Карпович Д.В. Аденоиды и аллергический ринит. Газета «Новости медицины и фармации». Аллергология и пульмонология. 2011;380:25–8. [Puhlik S.M., Nevert E.G., Karpovich D.V. Adenoids and allergic rhinitis. Newspaper «Novosti mediciny i farmacii». Allergologiya i pul’monologiya. 2011;380:25–8. (In Russ.)].
  5. Wise S.K., Lin S.Y., Toskala E., et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. Allergy and Rhinology. 2018;8(2):108–352. doi: 10.1002/alr.22073.
  6. Poorey V.K., Soni S., Thakur P. et al. Effect of Nasal Allergy Over Spirometric Parameters: A Prospective Study. Indian J Otolaryngol Head Neck Surg. 2016;68(1):6–10. doi: 10.1007/s12070- 015-0876-x.
  7. Reddel H.K., Bacharier L.B., Boulet L.-P., et al. Global Strategy for Asthma Management and Prevention (2022 update). URL: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf
  8. Козлов В.А., Савченко А.А., Кудрявцев И.В. и др. Клиническая иммунология. Красноярск: Поликор, 2020. 386 с. [Kozlov V.A., Savchenko A.A., Kudryavtsev I.V. et al. Clinical immunology. Krasnoyarsk: Polikor; 2020. 386 p. (In Russ.)].
  9. Cho K.-S., Kim S.H., Hong S.-L., et al. Local Atopy in Childhood Adenotonsillar Hypertrophy. Am J Rhinol & Allergy. 2018;32(3):160–66. doi: 10.1177/1945892418765003.
  10. Niedzielski A. et al. Adenoid hypertrophy in children: a narrative review of pathogenesis and clinical relevance. BMJ Paediatrics Open. 2023;7(1):e001710. doi: 10.1136/bmjpo-2022-001710.
  11. Емелина Ю.Н., Зурочка А.В. Содержание цитокинов в назальном секрете у детей с сочетанными формами респираторной пыльцевой аллергии до и после 3 курсов сублингвальной аллергенспецифической иммунотерапии. Медицинская иммунология. 2016;18(5):443–50. [Emelina Yu.N., Zurochka A.V. Cytokine content in nasal secretions in children with combined forms of respiratory pollen allergy before and after 3 courses of sublingual allergen-specific immunotherapy. Medicinskaya immunologiya. 2016;18(5):443–450. (In Russ.)].

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2024

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>